Biogen Idec has signed a three-year enterprise license for PharmaPros' automated study management solution, Dataflow Manager. The deal includes unlimited studies and unlimited users for the duration of the license.

Biogen’s initial implementation of Dataflow Manager consists of four in-progress phase III clinical trials that spanned 36 countries, with more than 5,000 patients and 300 sites, using outsourced service providers for global monitoring and data management. Dataflow Manager provided immediate visibility into the progress of the ongoing studies, delivering real-time analytics on very large data sets including more than 300,000 forms per study, and one million lab records.

PharmaPros is a technology solutions provider specializing in data and workflow management for clinical trials.

"This is an exciting opportunity for PharmaPros, and our product. The initial implementation with Biogen allowed us to test and prove that Dataflow Manager can scale to large, complex clinical trials with very challenging study management criteria, and that both our cloud computing and SaaS delivery model work for clinical trials of any size," said Nick Neri, vice president of technology at PharmaPros.